Day One Biopharmaceutical
DAWN
Reported
Wednesday, October 30
Q3 2024 Earnings
| (USD) | Expected | Reported | Surprise $ | Surprise % |
|---|---|---|---|---|
| EPS | -0.41 | 0.38 | 0.79 | 192.68% |
| Revenue | 23.5M | 93.8M | 70.2M | 298.31% |
WhatIF - Earnings
EPS Beat Expectations by $0.79
Day One Biopharmaceutical (DAWN:NASDAQ) has never beaten EPS by this much before
There’s a first time for everything